Sectors
BDSX
Biodesix, Inc.
24.31
2 x 24.13
3 x 24.35
bid
ask
-
0.55
2.21%
undefined @ 04:00 PM
24.33 +0.02 (0.08%)
| Ytd | 257.50% | |
| 1y | 211.67% |
23.32
day range
25.52
5.26
52 week range
25.52
| Open | 24.17 | Prev Close | 24.86 | Low | 23.32 | High | 25.52 | Mkt Cap | 197.89M |
| Vol | 94.90K | Avg Vol | 72.02K | EPS | -3.17 | P/E | -7.67 | Forward P/E | -6.64 |
| Beta | 1.21 | Short Ratio | 0.83 | Inst. Own | 42.83% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-04 | 50-d Avg | 19.70 | 200-d Avg | 13.22 | 1yr Est | 3.10 |
| Income Statement | |||
| Total Revenue | 26.86M | ||
| Revenues (USD) | 26.86M | ||
| Cost of Revenue | 4.82M | ||
| Gross Profit | 22.04M | ||
| Operating Expenses | 27.43M | ||
| Research and Development Expense | 3.14M | ||
| Selling, General and Administrative Expense | 24.28M | ||
| Operating Income | -5.39M | ||
| Interest Expense | 1.98M | ||
| Net Income | -7.27M | ||
| Net Income Common Stock | -7.27M | ||
| Net Income Common Stock (USD) | -7.27M | ||
| Consolidated Income | -7.27M | ||
| Earnings per Basic Share | -0.71 | ||
| Earnings per Basic Share (USD) | -0.71 | ||
| Earnings per Diluted Share | -0.71 | ||
| Earning Before Interest & Taxes (EBIT) | -5.29M | ||
| Earning Before Interest & Taxes (USD) | -5.29M | ||
| Weighted Average Shares | 10.30M | ||
| Weighted Average Shares Diluted | 10.30M | ||
| Balance Sheet | |||
| Cash and Equivalents | 30.00M | ||
| Cash and Equivalents (USD) | 30.00M | ||
| Trade and Non-Trade Receivables | 9.11M | ||
| Current Assets | 43.57M | ||
| Property, Plant & Equipment Net | 27.35M | ||
| Total Assets | 95.33M | ||
| Debt Current | 1.61M | ||
| Total Debt | 71.80M | ||
| Current Liabilities | 15.29M | ||
| Debt Non-Current | 70.19M | ||
| Total Liabilities | 86.18M | ||
| Accumulated Retained Earnings (Deficit) | -512.83M | ||
| Shareholders Equity | 9.14M | ||
| Shareholders Equity (USD) | 9.14M | ||
| Assets Non-Current | 51.76M | ||
| Total Debt (USD) | 71.80M | ||
| Deferred Revenue | 205.00K | ||
| Goodwill and Intangible Assets | 18.01M | ||
| Liabilities Non-Current | 70.89M | ||
| Trade and Non-Trade Payables | 2.16M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.41M | ||
| Net Cash Flow from Financing | 6.24M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 4.42M | ||
| Capital Expenditure | -254.00K | ||
| Issuance (Purchase) of Equity Shares | 6.68M | ||
| Issuance (Repayment) of Debt Securities | -12.00K | ||
| Net Cash Flow from Investing | -254.00K | ||
| Net Cash Flow from Operations | -1.56M | ||
| Share Based Compensation | 820.00K | ||